Leuprolide acetate and acetylcholinesterase inhibitors or NMDA receptor antagonists for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2005322611 (hide)

International Classifications

Event Publications

5 July 2007 PCT application entered the National Phase

PCT publication WO2006/071274 Priority application(s): WO2006/071274

5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

9 September 2010 Section 223 Application Allowed

Voyager Pharmaceutical Corporation The time in which to request examination has been extended to 13 Sep 2010. Address for service in Australia - Peter Maxwell & Associates Level 6 60 Pitt Street Sydney NSW 2000 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.